Saturday, 8 August 2009

Lodosyn




In the US, Lodosyn (carbidopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat GTP-CH Deficiency, Neuroleptic Malignant Syndrome and Parkinsonian Tremor.

US matches:

  • Lodosyn

Ingredient matches for Lodosyn



Carbidopa

Carbidopa is reported as an ingredient of Lodosyn in the following countries:


  • United States

International Drug Name Search

No comments:

Post a Comment